title: Stakeholders say FDA must change REMS program.
authors.affiliation: TReinke@ManagedCareMag.com
authors.forename: Thomas
authors.initials: T
authors.lastname: Reinke
mesh_terms: D064420:Drug-Related Side Effects and Adverse Reactions; D018166:Health Care Reform; D006801:Humans; D010595:Pharmacists; D018570:Risk Assessment / Q000379:methods*; D012308:Risk Management / Q000379:methods*; D014481:United States; D014486:United States Food and Drug Administration